Company / Book Value per Share
Prime Medicine, Inc. Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.922
FY2025
5-year range
-$12.043 / $9.757
FY2021-FY2025
Trend
-32.6%
vs FY2024
Sector context
#167 of 209
Health Care
What the data says
Prime Medicine, Inc.'s book value per share of $0.922 is lower than 80% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 3 consecutive years, from $9.757 in FY2022 to $0.922 in FY2025.
Based on SEC 10-K filings.
$0.922 in FY2025 with a 5-year CAGR of +0.8%.
Declined from $1.463 to $0.922 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -54.5%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 209This company $0.922 Sector average $189.406
▼
-99.5% below sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, book value per share decreased 32.6% year-over-year.
- Ranks #167 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.922 | -32.6% |
| FY2024 | $1.367 | -6.6% |
| FY2023 | $1.463 | -85.0% |
| FY2022 | $9.757 | +181.0% |
| FY2021 | -$12.043 | -1459.7% |
| FY2020 | $0.886 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026